What proton pump inhibitor (PPI) and dose should be given to a one‑month‑old infant weighing about 4 kg?

PPI Selection and Dosing for a One-Month-Old Infant

For a one-month-old infant weighing approximately 4 kg, consider ranitidine (an H2-receptor antagonist) at 5-10 mg/kg/day divided in 2-3 doses as the preferred first-line acid suppression therapy, rather than a PPI, unless there is documented erosive esophagitis requiring more potent acid suppression. 1

Critical Context: Limited Evidence for PPIs in Young Infants

The use of PPIs in infants under 1 year of age requires careful consideration, as placebo-controlled trials have not demonstrated superiority of PPIs over placebo for reduction in irritability in this age group. 1 The American Academy of Pediatrics guidelines specifically caution against overuse or misuse of PPIs in infants with reflux, noting particular concerns about increased risk of lower respiratory tract infections. 1

If PPI Therapy Is Deemed Necessary

FDA-Approved Options for Infants ≥1 Month

If a PPI is clinically indicated (such as for documented erosive esophagitis), the FDA-approved options for infants ≥1 month old include: 1

• Esomeprazole: 0.7-3.3 mg/kg/day (FDA-approved for ages 1 month-17 years)

  • For a 4 kg infant: approximately 2.8-13.2 mg daily
  • Available as capsule contents that can be sprinkled on soft foods or administered in juice through nasogastric tube 1

• Lansoprazole: 0.7-3.0 mg/kg/day (FDA-approved for ages 1-17 years)

  • For a 4 kg infant: approximately 2.8-12 mg daily
  • Available as capsule contents that can be sprinkled on soft foods or administered through nasogastric tube 1

• Omeprazole: 0.7-3.3 mg/kg/day (FDA-approved for ages 2-16 years, though used off-label in younger infants)

  • For a 4 kg infant: approximately 2.8-13.2 mg daily
  • Available as capsule contents that can be sprinkled on soft foods 1

Practical Dosing Considerations

Start at the lower end of the dosing range (0.7-1.0 mg/kg/day) and titrate based on clinical response. 1 The wide dosage range reflects significant interindividual variability in PPI pharmacokinetics in children. 1

For this 4 kg infant, a reasonable starting dose would be:

• Esomeprazole 2.5-4 mg daily
• Lansoprazole 3-4 mg daily
• Omeprazole 3-4 mg daily

Important Safety Considerations

Acid suppression therapy in infants carries specific risks that must be weighed against potential benefits: 1

• Increased risk of community-acquired pneumonia 1
• Increased risk of gastroenteritis 1
• Increased risk of candidemia 1
• Increased risk of necrotizing enterocolitis in preterm infants 1
• Potential for enterochromaffin cell hyperplasia with prolonged use (>2.5 years) 1

Alternative: H2-Receptor Antagonists

H2-receptor antagonists may be more appropriate as first-line therapy for this age group: 1

• Ranitidine: 5-10 mg/kg/day divided in 2-3 doses (FDA-approved for ages 1 month-16 years)

  • For a 4 kg infant: 20-40 mg daily divided into 2-3 doses
  • Available as peppermint-flavored syrup 1

• Famotidine: 1 mg/kg/day divided in 2 doses (FDA-approved for ages 1-16 years)

  • For a 4 kg infant: 4 mg daily divided into 2 doses
  • Available as cherry-banana-mint flavored oral suspension 1

Note that H2RAs are less effective than PPIs for healing erosive esophagitis but may be sufficient for uncomplicated reflux symptoms, and tachyphylaxis can develop within 6 weeks. 1

Clinical Algorithm

1. Confirm the indication: Document whether symptoms represent physiologic reflux versus pathologic GERD requiring pharmacotherapy 1

2. Consider non-pharmacologic interventions first: Positioning, feeding modifications, and parental reassurance 2

3. If medication is necessary:

   • Start with H2RA (ranitidine or famotidine) for uncomplicated reflux 1
   • Reserve PPIs for documented erosive esophagitis or H2RA failure 1

4. If PPI is chosen: Start with esomeprazole or lansoprazole at 0.7-1.0 mg/kg/day given the FDA approval for this age group 1

5. Monitor closely for efficacy and adverse effects, particularly respiratory infections 1